The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017

Frontiers in Oncology
Peng JiZhi-Ming Shao

Abstract

Background: Data on burden and changing trends of breast cancer are of value for policymaking. We aimed to determine the pattern of breast cancer incidence, mortality, and disability-adjusted life-years (DALYs), as well as temporal trends, from 1990 to 2017. Methods: We collected detailed information on breast cancer between 1990 and 2017 using the results of the Global Burden of Disease study. The number of incident cases, deaths, and DALYs attributable to breast cancer are reported as well as age-standardized rates. Estimated annual percentage changes (EAPCs) in age-standardized rates were calculated to quantify the temporal trends. Moreover, the attributable burden to breast cancer risk factors was also estimated. Results: There were 1,960,682 incident cases and 611,625 deaths of breast cancer globally in 2017, contributing to 17,708,600 DALYs. The age-standardized incidence rates (ASIRs) increased between 1990 and 2017, while the age-standardized mortality rates and DALY rates decreased. The corresponding EAPCs were 0.41, -0.62, and -0.56, respectively. These trends were heterogeneous across regions and countries. The increase in the ASIRs was more prominent in countries with a low sociodemographic index. The percentages of...Continue Reading

References

Feb 19, 2000·Cancer Causes & Control : CCC·B F HankeyB K Edwards
Aug 30, 2000·Nature·C M PerouD Botstein
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Apr 20, 2007·The New England Journal of Medicine·Peter M RavdinDonald A Berry
Jan 18, 2008·The New England Journal of Medicine·Peggy Porter
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K David VoducHagen Kennecke
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagen KenneckeKaren Gelmon
Jul 22, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ahmedin JemalElizabeth M Ward
Jan 10, 2012·Population Health Metrics·Kyle J ForemanChristopher Jl Murray
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Lawrence H KushiUNKNOWN American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee
Nov 23, 2012·The New England Journal of Medicine·Archie Bleyer, H Gilbert Welch
Jan 9, 2014·JAMA : the Journal of the American Medical Association·Marie NgEmmanuela Gakidou
May 30, 2014·The Lancet Oncology·Lei FanPaul E Goss
Dec 4, 2014·The Lancet Oncology·Melina ArnoldIsabelle Soerjomataram
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Mar 19, 2015·Breast Cancer Research and Treatment·Karin KastPauline Wimberger
Jul 7, 2015·JAMA Internal Medicine·Charles HardingRichard Wilson
Sep 12, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Carol E DeSantisAhmedin Jemal
Nov 8, 2015·Breast Cancer Research and Treatment·Alina MacacuPeter Boyle
May 1, 2016·Alcoholism, Clinical and Experimental Research·Kevin D ShieldJürgen Rehm
May 12, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Mahshid GhonchehHamid Salehiniya
Nov 7, 2016·Lancet·Ophira GinsburgLesong Conteh
Nov 21, 2016·Lancet·Nadia Harbeck, Michael Gnant
Apr 20, 2017·JAMA Surgery·Olivia M ValenciaHassan Aziz
May 27, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Yoon-Jung ChoiJi-Ho Lee
Nov 14, 2017·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·K HidayatB-M Shi
Jan 22, 2019·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Xuyu ChenXiaodong Tan
Jan 23, 2019·JAMA : the Journal of the American Medical Association·Adrienne G Waks, Eric P Winer
Feb 23, 2019·The Lancet Infectious Diseases·UNKNOWN GBD 2017 Typhoid and Paratyphoid Collaborators
Feb 15, 2020·Breast Cancer Research and Treatment·Zhilin ChenPingming Fan

❮ Previous
Next ❯

Citations

Aug 14, 2020·International Journal of Environmental Research and Public Health·Dun-Sol GoSeok-Jun Yoon
Feb 17, 2021·Aging·Junjie HuangMartin Cs Wong
Aug 26, 2021·Climacteric : the Journal of the International Menopause Society·Z Stevens, J Hellig
Dec 22, 2021·Cancer Control : Journal of the Moffitt Cancer Center·Achamyelesh GebretsadikDereje G Negera

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.